LON:TV2H Thames Ventures VCT 2 Healthcare Shs (TV2H) Share Price, News & Analysis → Kiss of death from Joe Biden (From Porter & Company) (Ad) Free TV2H Stock Alerts GBX 47.50 0.00 (0.00%) (As of 05/30/2024 01:46 AM ET) Add Compare Share Share Today's Range 47.50▼ 47.5050-Day Range 47.50▼ 47.5052-Week Range 47.50▼ 67.50VolumeN/AAverage Volume76,646 shsMarket Capitalization£11.19 millionP/E RatioN/ADividend Yield2.11%Price TargetN/A Stock AnalysisStock AnalysisChartCompetitorsDividendStock AnalysisChartCompetitorsDividend Ad Porter & CompanyKiss of death from Joe BidenIn this new documentary, you’ll discover the truth about Trump’s criminal conviction, who’s really pulling the puppet strings, and why this is just phase one in their dark plan to reshape America. It’s not just about blocking Trump’s re-election… To get all the details, go here now. About Thames Ventures VCT 2 Healthcare ShsThames Ventures VCT 2 plc is a venture capital trust specializing in qualifying venture capital and non-qualifying structured products, secured loans and fixed income securities investments. Secured loans will be secured on assets held by the investee company.Read More TV2H Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart TV2H Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Industry, Sector and Symbol Stock ExchangeLON SectorFinancial Services Industry Asset Management Sub-IndustryN/A Current SymbolLON:TV2H CUSIPN/A CIKN/A Webwww.downing.co.uk Phone44-20-3667-8100FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares23,550,000Free FloatN/AMarket Cap£11.19 million OptionableNot Optionable BetaN/A Key ExecutivesMr. Ed SimpsonPartner & Head of Energy and InfrastructureMr. Martin Robertson (Age 57)Partner and Head Dr. Kostas Manolis Ph.D.PartnerMr. Colin George Eric Corbally (Age 55)Partner and Head Mr. Grant Leslie WhitehouseCompany Sec.Key CompetitorsNB Global Monthly Income Fund Ltd GBPLON:NBMILighthouse GroupLON:LGTRiver and Mercantile GroupLON:RIVScotGemsLON:SGEMBlackRock Income and GrowthLON:BRIGView All Competitors TV2H Stock Analysis - Frequently Asked Questions How have TV2H shares performed in 2024? Thames Ventures VCT 2 Healthcare Shs' stock was trading at GBX 51.05 at the beginning of 2024. Since then, TV2H shares have decreased by 7.0% and is now trading at GBX 47.50. View the best growth stocks for 2024 here. How often does Thames Ventures VCT 2 Healthcare Shs pay dividends? What is the dividend yield for Thames Ventures VCT 2 Healthcare Shs? Thames Ventures VCT 2 Healthcare Shs announced a dividend on Monday, July 31st. Investors of record on Thursday, August 31st will be given a dividend of GBX 1.25 per share on Friday, September 29th. This represents a yield of 2.03%. The ex-dividend date is Thursday, August 31st. The official announcement can be accessed at this link. Read our dividend analysis for TV2H. Is Thames Ventures VCT 2 Healthcare Shs a good dividend stock? Thames Ventures VCT 2 Healthcare Shs (LON:TV2H) pays an annual dividend of GBX 1 per share and currently has a dividend yield of 2.29%. Read our dividend analysis for TV2H. How do I buy shares of Thames Ventures VCT 2 Healthcare Shs? Shares of TV2H stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:TV2H) was last updated on 5/31/2024 by MarketBeat.com Staff From Our Partners[Urgent!] Generational Wealth GameplanCrypto 101 MediaThis unknown company solves the biggest issue with AIManward PressWho are Nvidia’s New Silent Partners?Weiss RatingsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarBill Gates is all about this tiny $2 stockTimothy SykesDems have chosen Biden replacement?Paradigm PressGet out of dollars—get into America’s new money insteadStansberry ResearchDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin Pro Adding Choose a watchlist: Watchlist My Default Watchlist Adding Thames Ventures VCT 2 Healthcare Shs You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.